Livzon Pharmaceutical Group Inc Financial Flexibility Index
Livzon Pharmaceutical Group Inc financial flexibility index. Livzon Pharmaceutical Group Inc (000513) has a Financial Flexibility Index of 0.09x as of December 2025. Free cash flow of CN¥704.42 Million (operating CF CN¥625.70 Million minus capex CN¥78.72 Million) represents 0% of total liabilities (CN¥8.20 Billion). See Livzon Pharmaceutical Group Inc (000513) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Livzon Pharmaceutical Group Inc (1998–2025)
Financial flexibility index of Livzon Pharmaceutical Group Inc from 1998 to 2025. Historical Financial Flexibility Index trend for Livzon Pharmaceutical Group Inc across 28 annual periods. Check Livzon Pharmaceutical Group Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Livzon Pharmaceutical Group Inc Financial Flexibility Index by Year (1998–2025)
Livzon Pharmaceutical Group Inc financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Livzon Pharmaceutical Group Inc. For the full cash flow conversion analysis, see Livzon Pharmaceutical Group Inc (000513) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥3.75 Billion | CN¥3.18 Billion | CN¥8.20 Billion | ▲ +23.2% |
| 2024 | 0.37x | CN¥3.55 Billion | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -6.1% |
| 2023 | 0.40x | CN¥4.07 Billion | CN¥3.25 Billion | CN¥10.28 Billion | ▲ +5.9% |
| 2022 | 0.37x | CN¥3.71 Billion | CN¥2.77 Billion | CN¥9.93 Billion | ▼ -6.2% |
| 2021 | 0.40x | CN¥3.21 Billion | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -1.4% |
| 2020 | 0.40x | CN¥2.81 Billion | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +6.4% |
| 2019 | 0.38x | CN¥2.17 Billion | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +24.0% |
| 2018 | 0.31x | CN¥1.74 Billion | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -11.3% |
| 2017 | 0.35x | CN¥1.61 Billion | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -28.3% |
| 2016 | 0.48x | CN¥1.65 Billion | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +11.9% |
| 2015 | 0.43x | CN¥1.40 Billion | CN¥927.79 Million | CN¥3.27 Billion | ▲ +0.1% |
| 2014 | 0.43x | CN¥1.38 Billion | CN¥717.39 Million | CN¥3.22 Billion | ▼ -6.5% |
| 2013 | 0.46x | CN¥1.36 Billion | CN¥439.99 Million | CN¥2.96 Billion | ▼ -16.9% |
| 2012 | 0.55x | CN¥1.36 Billion | CN¥593.96 Million | CN¥2.45 Billion | ▼ -16.8% |
| 2011 | 0.66x | CN¥1.06 Billion | CN¥708.20 Million | CN¥1.59 Billion | ▼ -30.0% |
| 2010 | 0.95x | CN¥970.25 Million | CN¥633.30 Million | CN¥1.02 Billion | ▲ +36.2% |
| 2009 | 0.70x | CN¥626.29 Million | CN¥494.88 Million | CN¥898.92 Million | ▲ +80.4% |
| 2008 | 0.39x | CN¥420.70 Million | CN¥345.18 Million | CN¥1.09 Billion | ▲ +8.5% |
| 2007 | 0.36x | CN¥339.83 Million | CN¥248.55 Million | CN¥954.80 Million | ▼ -5.8% |
| 2006 | 0.38x | CN¥406.91 Million | CN¥226.46 Million | CN¥1.08 Billion | ▼ -16.3% |
| 2005 | 0.45x | CN¥417.79 Million | CN¥161.07 Million | CN¥925.20 Million | ▲ +41.8% |
| 2004 | 0.32x | CN¥327.94 Million | CN¥181.46 Million | CN¥1.03 Billion | ▼ -24.7% |
| 2003 | 0.42x | CN¥403.57 Million | CN¥300.01 Million | CN¥954.70 Million | ▼ -3.1% |
| 2002 | 0.44x | CN¥317.27 Million | CN¥213.65 Million | CN¥727.05 Million | ▲ +17.9% |
| 2001 | 0.37x | CN¥236.63 Million | CN¥155.15 Million | CN¥639.37 Million | ▲ +115.1% |
| 2000 | 0.17x | CN¥100.01 Million | CN¥38.52 Million | CN¥581.24 Million | ▼ -68.6% |
| 1999 | 0.55x | CN¥319.67 Million | CN¥246.23 Million | CN¥583.95 Million | ▲ +1792.1% |
| 1998 | 0.03x | CN¥13.53 Million | CN¥-18.21 Million | CN¥467.61 Million | — |